11. Semi-automatic signature-based segmentation method for quantification of neuromelanin in substantia nigraGašper Zupan, Dušan Šuput, Zvezdan Pirtošek, Andrej Vovk, 2019, original scientific article Keywords: Parkinson’s disease, neuromelanin, brainstem, neuroimaging, substantia nigra, segmentation Full text (file, 1,56 MB) This document has more files! More... |
12. Natural and synthetic derivatives of hydroxycinnamic acid modulating the pathological transformation of amyloidogenic proteinsVladimir I. Muronetz, Kseniya Barinova, Sofia Kudryavtseva, Maria Medvedeva, Aleksandra Melnikova, Irina Sevostyanova, Pavel Semenyuk, Yulia Stroylova, Matej Sova, 2020, review article Keywords: neurodegenerative diseases, curcumin, derivatives of hydroxycinnamic acid, amyloid, α-synuclein, prion protein, amyloid fibrils, prevention of amyloid transformation, Parkinson's disease Full text (file, 4,40 MB) This document has more files! More... |
13. Assessment of the telomere length and its effect on the symptomatology of Parkinson's diseaseTina Levstek, Sara Redenšek Trampuž, Maja Trošt, Vita Dolžan, Katarina Trebušak Podkrajšek, 2021, original scientific article Keywords: Parkinson's disease, telomere length, levodopa treatment, telomere attrition, dementia Full text (file, 737,20 KB) This document has more files! More... |
14. Switching and combining device-aided therapies in advanced Parkinson’s diseaseDejan Georgiev, Sentilija Delalić, Nina Zupančič-Križnar, Achinoam Socher, Tanya Gurevich, Maja Trošt, 2022, original scientific article Keywords: advanced Parkinson’s disease, deep brain stimulation of the subthalamic nucleus, L-dopa/carbidopa intestinal gel infusion, continuous subcutaneous apomorphine infusion Full text (file, 1020,95 KB) This document has more files! More... |
15. Serotonin-related functional genetic variants affect the occurrence of psychiatric and motor adverse events of dopaminergic treatment in Parkinson’s diseaseSara Redenšek Trampuž, Tanja Blagus, Maja Trošt, Vita Dolžan, 2022, original scientific article Keywords: Parkinson’s disease, motor complications, visual hallucinations, impulse control disorders, dyskinesia, polymorphism, serotonin, adverse event, pharmacogenomics Full text (file, 550,02 KB) This document has more files! More... |
16. Adverse effects of levodopa/carbidopa intrajejunal gel treatmentTomaž Rus, Maša Premzl, Nina Zupančič-Križnar, Milica Gregorič Kramberger, Robert Rajnar, Lidija Ocepek, Zvezdan Pirtošek, Maja Trošt, 2022, original scientific article Keywords: advanced Parkinson's disease, levodopa-carbidopa intestinal gel, percutaneous endoscopic gastrojejunostomy, adverse effects, health-related quality of life Full text (file, 1,14 MB) This document has more files! More... |
|
18. Clinical and clinical-pharmacogenetic models for prediction of the most common psychiatric complications due to dopamingeric treatment in Parkinson's diseaseSara Redenšek Trampuž, Barbara Jenko Bizjan, Maja Trošt, Vita Dolžan, 2020, original scientific article Keywords: Parkinson's disease, polymorphism, pharmacogenetics, impulse control disorders, predictive model, psychiatric complications, visual hallucinations Full text (file, 3,37 MB) This document has more files! More... |
19. Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse eventsSara Redenšek Trampuž, Tilen Kristanc, Tanja Blagus, Maja Trošt, Vita Dolžan, 2022, original scientific article Keywords: vitamin D receptor, Parkinson’s disease, biomarker, risk, susceptibility, adverse events, vitamin D, polymorphism Full text (file, 279,78 KB) This document has more files! More... |
20. Synthesis, molecular docking, and neuroprotective effect of 2-methylcinnamic acid amide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) - an induced Parkinson’s disease modelMaya Chochkova, Rusi Rusew, Reni Kalfin, Lyubka Tancheva, Maria Lazarova, Hristina Sbirkova-Dimitrova, Andrey Popatanasov, Krasimira Tasheva, Boris Shivachev, Nejc Petek, Martin Štícha, 2022, original scientific article Keywords: amantadine, 2-methylcinnamic acid, single crystal X-ray diffraction, Parkinson's disease Full text (file, 4,34 MB) This document has more files! More... |